TY - JOUR
T1 - Epo-IGF1R cross talk expands stress-specific progenitors in regenerative erythropoiesis and myeloproliferative neoplasm
AU - Hsieh, Hsi Hsien
AU - Yao, Huiyu
AU - Ma, Yue
AU - Zhang, Yuannyu
AU - Xiao, Xue
AU - Stephens, Helen
AU - Wajahat, Naureen
AU - Chung, Stephen S.
AU - Xu, Lin
AU - Xu, Jian
AU - Rampal, Raajit K.
AU - Huang, Lily Jun shen
N1 - Funding Information:
This study was supported by research funding from the National Heart, Lung, and Blood Institute ( R01HL089966) to L.J.H., National Institute of Diabetes and Digestive and Kidney Diseases ( R01DK111430) and National Cancer Institute ( R01CA230631) to J.X., National Human Genome Research Institute (UM1 HG011996) and National Cancer Institute ( R01CA262781 , R21CA259771 , and P30CA142543) to L.X., National Cancer Institute ( K08CA194275) to S.S.C., National Cancer Institute ( P01CA108671) to R.K.R., Rally Foundation (L.X.), the Cancer Prevention Research Institute of Texas ( RP180805 and RP200103 to L.X.; RR180046 to S.S.C.), American Society of Hematology (Junior Faculty Scholar Award to S.S.C.), Memorial Sloan Kettering Cancer Center ( P30CA008748 to R.K.R.), and Harold C. Simmons Comprehensive Cancer Center (pilot translational grant to L.J.H.), and funds from Incyte, Constellation, Stemline, and Zentalis to R.K.R.
Publisher Copyright:
© 2022 The American Society of Hematology
PY - 2022/12/1
Y1 - 2022/12/1
N2 - We found that in regenerative erythropoiesis, the erythroid progenitor landscape is reshaped, and a previously undescribed progenitor population with colony-forming unit-erythroid (CFU-E) activity (stress CFU-E [sCFU-E]) is expanded markedly to restore the erythron. sCFU-E cells are targets of erythropoietin (Epo), and sCFU-E expansion requires signaling from the Epo receptor (EpoR) cytoplasmic tyrosines. Molecularly, Epo promotes sCFU-E expansion via JAK2- and STAT5-dependent expression of IRS2, thus engaging the progrowth signaling from the IGF1 receptor (IGF1R). Inhibition of IGF1R and IRS2 signaling impairs sCFU-E cell growth, whereas exogenous IRS2 expression rescues cell growth in sCFU-E expressing truncated EpoR-lacking cytoplasmic tyrosines. This sCFU-E pathway is the major pathway involved in erythrocytosis driven by the oncogenic JAK2 mutant JAK2(V617F) in myeloproliferative neoplasm. Inability to expand sCFU-E cells by truncated EpoR protects against JAK2(V617F)-driven erythrocytosis. In samples from patients with myeloproliferative neoplasm, the number of sCFU-E-like cells increases, and inhibition of IGR1R and IRS2 signaling blocks Epo-hypersensitive erythroid cell colony formation. In summary, we identified a new stress-specific erythroid progenitor cell population that links regenerative erythropoiesis to pathogenic erythrocytosis.
AB - We found that in regenerative erythropoiesis, the erythroid progenitor landscape is reshaped, and a previously undescribed progenitor population with colony-forming unit-erythroid (CFU-E) activity (stress CFU-E [sCFU-E]) is expanded markedly to restore the erythron. sCFU-E cells are targets of erythropoietin (Epo), and sCFU-E expansion requires signaling from the Epo receptor (EpoR) cytoplasmic tyrosines. Molecularly, Epo promotes sCFU-E expansion via JAK2- and STAT5-dependent expression of IRS2, thus engaging the progrowth signaling from the IGF1 receptor (IGF1R). Inhibition of IGF1R and IRS2 signaling impairs sCFU-E cell growth, whereas exogenous IRS2 expression rescues cell growth in sCFU-E expressing truncated EpoR-lacking cytoplasmic tyrosines. This sCFU-E pathway is the major pathway involved in erythrocytosis driven by the oncogenic JAK2 mutant JAK2(V617F) in myeloproliferative neoplasm. Inability to expand sCFU-E cells by truncated EpoR protects against JAK2(V617F)-driven erythrocytosis. In samples from patients with myeloproliferative neoplasm, the number of sCFU-E-like cells increases, and inhibition of IGR1R and IRS2 signaling blocks Epo-hypersensitive erythroid cell colony formation. In summary, we identified a new stress-specific erythroid progenitor cell population that links regenerative erythropoiesis to pathogenic erythrocytosis.
UR - http://www.scopus.com/inward/record.url?scp=85141466700&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85141466700&partnerID=8YFLogxK
U2 - 10.1182/blood.2022016741
DO - 10.1182/blood.2022016741
M3 - Article
C2 - 36054916
AN - SCOPUS:85141466700
SN - 0006-4971
VL - 140
SP - 2371
EP - 2384
JO - Blood
JF - Blood
IS - 22
ER -